Condition
Mesothelioma
Estimated Enrollment: 36
Age Group: 18 Years to 80 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Other
Study ID Numbers: H-36460
Study First Received: July 16, 2016
Last Updated: March 24, 2017
Estimated Primary Completion Date: July 2018
Primary Outcome Measures:
Safety Maximum Tolerated Dose of HIOC with cisplatin and pemetrexed for Malignant Pleural Mesothelioma.
Sponsors and Collaborators:
Baylor College of Medicine
Website Link: https://ClinicalTrials.gov/show/NCT02838745
